Research and development

10 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: rnd

reported (US GAAP), not pro forma; includes xAI and X Holdings retroactively in all periods FY2023–Q2 2026 (combination under common control, per S-1/424B4). Pro forma values: metrics with suffix _pro_forma.

Value

$3.5B

Period

Q1 2026, ended Mar 31, 2026 · quarterly value (3 months, not cumulative)

Source

S-1, filed May 20, 2026 · 0001628280-26-036936

Location

Consolidated Statements of Operations (unaudited) | row 'Research and development' | column 2026-01-01–2026-03-31

Confidence

0.9 – extracted from text/tables in 8-K Ex.99, 10-K or prospectus (S-1/424B4, not XBRL-tagged), source location stored

Basis

Basis: reported (US GAAP, as in the filing), NOT pro forma. Includes xAI and X Holdings retroactively in ALL periods (FY2023–Q2 2026), because the acquisitions (X by xAI Mar 28, 2025, xAI by SpaceX Feb 2, 2026) are transactions under common control. S-1/424B4: “Our audited consolidated financial statements and related notes have been prepared to reflect the retrospective combination of the companies for all periods presented as the acquisitions of xAI and X Holdings were accounted for as transactions between entities under common control.” pro forma values only as separate metrics *_pro_forma.

Versions